Macrolactins from marine-derived bacillus subtilis b5 bacteria as inhibitors of inducible nitric oxide and cytokines expression

26Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

In order to find new natural products with anti-inflammatory activity, chemical investigation of a 3000-meter deep-sea sediment derived bacteria Bacillus subtilis B5 was carried out. A new macrolactin derivative was isolated and identified as 7,13-epoxyl-macrolactin A (1). Owing to the existence of the epoxy ring, 1 exhibited a significant inhibitory effect on the expression of inducible nitric oxide and cytokines, compared with previously isolated known macrolactins (2-5). Real-time Polymerase Chain Reaction (PCR) analysis showed that the new compound significantly inhibited the mRNA expressions of inducible nitric oxide synthase (iNOS), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Reverse transcription-PCR analysis demonstrated that the new compound reduced the mRNA expression level of IL-1β in a concentration-dependent manner.

Cite

CITATION STYLE

APA

Yan, X., Zhou, Y. X., Tang, X. X., Liu, X. X., Yi, Z. W., Fang, M. J., … Qiu, Y. K. (2016). Macrolactins from marine-derived bacillus subtilis b5 bacteria as inhibitors of inducible nitric oxide and cytokines expression. Marine Drugs, 14(11). https://doi.org/10.3390/md14110195

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free